Race Oncology Limited (RAONF)

Race Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 10, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	149	207	133	214	395	56
Market Cap Growth	55.97%	55.97%	-37.97%	-45.78%	602.32%	1741.59%
Enterprise Value	138	198	115	189	391	55
Last Close Price	1.22	0.83	1.45	2.60	3.10	-
PS Ratio	77.63	77.63	63.73	439.48	1360.92	511.48
PB Ratio	16.97	16.97	7.84	8.61	38.42	14.33
P/TBV Ratio	20.05	20.05	8.92	9.50	52.37	46.49
EV/Sales Ratio	55.37	74.21	55.32	387.06	1346.52	501.76
Asset Turnover	0.17	0.17	0.10	0.03	0.04	0.03
Quick Ratio	9.26	9.26	20.16	23.71	18.07	7.30
Current Ratio	9.32	9.32	20.44	24.09	20.24	8.20
Return on Equity (ROE)	-63.10%	-63.10%	-32.22%	-44.96%	-65.32%	-71.62%
Return on Assets (ROA)	-38.63%	-38.63%	-20.41%	-27.05%	-39.39%	-43.96%
Return on Capital (ROIC)	-41.34%	-41.34%	-21.26%	-28.10%	-40.95%	-45.75%
Earnings Yield	-4.45%	-4.45%	-4.97%	-3.60%	-1.20%	-4.72%
FCF Yield	-3.07%	-3.07%	-5.33%	-2.01%	-0.89%	-3.02%
Buyback Yield / Dilution	-2.35%	-2.35%	-4.83%	-17.06%	-22.86%	-33.50%
Total Shareholder Return	-2.35%	-2.35%	-4.83%	-17.06%	-22.86%	-33.50%

Source: S&P Capital IQ. Standard template. Financial Sources.